Navigation Links
Hypokalemia in Medical News

Prescription Copay Assistance for Patients taking Gleevec or Tasigna for Philadelphia chromosome-positive Chronic Myelogenous Leukemia (Ph+ CML)

... be used in patients with hypokalemia, hypomagnesemia, or long QT syndrome. hypokalemia or hypomagnesemia must be corrected prior to TASIGNA administration and ... QT prolongation Tasigna prolongs the QT interval. Correct hypokalemia or hypomagnesemia prior to administration and monitor periodically. Avoid ...

MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States

... MULTAQ treatment initiation. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. hypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be maintained in the normal ...

FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter

... Multaq(R) treatment initiation. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. hypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be maintained in the normal ...

Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia

... more common among Vaprisol-treated patients (3%) than among placebo-treated patients (0%). Other common adverse reactions were headaches (8%, 10%), hypokalemia (22%, 10%), orthostatic hypotension (14%, 6%), and pyrexia (11%, 5%) for Vaprisol 20mg/day and 40mg/day, respectively.(1 ) For full prescribing ...

GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US

... prolongs the QT interval in some patients. TYKERB should be administered with caution to patients who have or may develop prolongation of QTc. hypokalemia or hypomagnesemia should be corrected prior to TYKERB administration. Baseline and on-treatment electrocardiograms with QT measurement should be ...

Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical

... Failure to do so will result in return of the anemia and in development of incapacitating and irreversible damage to the nerves of the spinal cord. hypokalemia and sudden death may occur in severe megaloblastic anemia which is treated intensely with vitamin B12. Side effects thought to be related to ...

Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer

... prolongs the QT interval in some patients. TYKERB should be administered with caution to patients who have or may develop prolongation of QTc. hypokalemia or hypomagnesemia should be corrected prior to TYKERB administration. Baseline and on-treatment electrocardiograms with QT measurement should be ...

ReachMD XM 157 Announces Medical Information Feature on Treatment Options for Management of Hyponatremia

... more common among Vaprisol-treated patients (3%) than among placebo-treated patients (0%). Other common adverse reactions were headaches (8%, 10%), hypokalemia (22%, 10%), orthostatic hypotension (14%, 6%), and pyrexia (11%, 5%) for Vaprisol 20mg/day and 40mg/day, respectively. For more information about ...

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

... (14% vs 10%), pain in extremity (14% vs 9%), abdominal pain (14% vs 7%), paresthesia (13% vs 4%), herpes zoster (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), ...

Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products

... and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, hypokalemia and hypernatremia. Nausea and vomiting have been reported. Use with caution in diabetics. Kristalose(R) is contraindicated in patients who require a ...
Hypokalemia in Medical Technology

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... in patients with hypokalemia, hypomagnesemia, or long QT syndrome. hypokalemia or hypomagnesemia must be corrected prior to TASIGNA administration ... QT prolongation Tasigna prolongs the QT interval. Correct hypokalemia or hypomagnesemia prior to administration and monitor periodically. Avoid ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... be used in patients with hypokalemia, hypomagnesemia, or long QT syndrome. hypokalemia or hypomagnesemia must be corrected prior to Tasigna administration and ... QT prolongation Tasigna prolongs the QT interval. Correct hypokalemia or hypomagnesemia prior to administration and monitor periodically. Avoid ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... (14% vs 10%), pain in extremity (14% vs 9%), abdominal pain (14% vs 7%), paresthesia (13% vs 4%), herpes zoster (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... (14% vs 10%), pain in extremity (14% vs 9%), abdominal pain (14% vs 7%), paresthesia (13% vs 4%), herpes zoster (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), ...

Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

... (14% vs 10%), pain in extremity (14% vs 9%), abdominal pain (14% vs 7%), paresthesia (13% vs 4%), herpes zoster (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), ...

New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

... (14% vs 10%), pain in extremity (14% vs 9%), abdominal pain (14% vs 7%), paresthesia (13% vs 4%), herpes zoster (13% vs 4%), bronchitis (13% vs 8%), hypokalemia (13% vs 7%), hypertension (13% vs 7%), abdominal pain upper (12% vs 9%), hypotension (12% vs 3%), dyspepsia (11% vs 7%), nasopharyngitis (11% vs 8%), ...

Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting

... have been reported in patients receiving nilotinib. Tasigna should not be used in patients with hypokalemia, hypomagnesemia, or long QT syndrome. hypokalemia or hypomagnesemia must be corrected prior to Tasigna administration and should be periodically monitored. Drugs known to prolong the QT interval ...

Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

... (12.7%) and malaise (10.9%). The most common adverse reactions by IV route also included petechiae (45.8%), rigors (35.4%), weakness (35.4%) and hypokalemia (31.3%). Because treatment with Vidaza is associated with neutropenia and thrombocytopenia, complete blood counts should be performed as needed ...

Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

... (12.7%) and malaise (10.9%). The most common adverse reactions by IV route also included petechiae (45.8%), rigors (35.4%), weakness (35.4%) and hypokalemia (31.3%). Because treatment with Vidaza is associated with neutropenia and thrombocytopenia, complete blood counts should be performed as needed ...

MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule

... (12.7%) and malaise (10.9%). The most common adverse reactions by IV route also included petechiae (45.8%), rigors (35.4%), weakness (35.4%) and hypokalemia (31.3%). Because treatment with Vidaza is associated with neutropenia and thrombocytopenia, complete blood counts should be performed as needed ...
Hypokalemia in Medical Definition

Pathology

... , Lactic ) - Alkalosis ( Metabolic , Respiratory ) - Mixed disorder of acid-base balance - H 2 O Dehydration / Hypervolemia - K + hypokalemia / Hyperkalemia - Cl − Hyperchloremia / Hypochloremia Purine and pyrimidine Hyperuricemia - Lesch-Nyhan syndrome - Xanthinuria ...
Hypokalemia in Medical Dictionary

Hypokalemia

... hypokalemia - Abnormal decrease in blood potassium ... of 3.8 to 5.0 milliequivalents per liter. hypokalemia Definition: hypokalemia means low serum potassium (low blood ...

Arrhythmias

... of the heart ( cardiac arrhythmias ). Low serum potassium ( hypokalemia ) occurs when serum potassium falls below 3.0 mM. Various ... should be in the range of 3.8 to 5.0 milliequivalents per liter. hypokalemia can occur secondary to a drug side effect, vomiting , or excessive ...

Hyperkalemia

... Detect potassium levels in the blood that are too low ( hypokalemia ) or too high ( hyperkalemia ). This may be done for people being treated ... potassium in the blood instead of low levels. Either low potassium ( hypokalemia ) or high potassium ( hyperkalemia ) ... ...

Potassium

... treatment of potassium deficiency , treatment or prevention of hypokalemia . Product is bioequivalent to Key Pharmaceuticals' K-Dur 20. Field: ... immunosuppressant drugs may be given to reduce the inflammation . hypokalemia - Abnormal decrease in blood potassium concentration. Can result in ...

Aldosterone

... tract is the digestive tract. BARTTER'S SYNDROME - A clinical syndrome characterized by enlargement of certain kidney cells, alkalosis , hypokalemia , and increased production of the hormone aldosterone . Common in children and may be seen in dwarfism . Ad renal cortexThe outer tissue of ...

Alkalosis

... tranquilizers), ... BARTTER'S SYNDROME - A clinical syndrome characterized by enlargement of certain kidney cells, alkalosis , hypokalemia , and increased production of the hormone aldosterone . Common in children and may be seen in dwarfism . Environmental Causes Incorrect Water ...

Diarrhea

... from the nether regions, smell something awful and feel something wet all over your hand . OK, a diaper blowout, you think. Watery diarrhea hypokalemia (low blood potassium ), which can cause leg cramps Low acid in the stomach Dehydration Abdominal pain and cramp ing Weight loss ...

Digit

... and anti tumor medicines ( chemotherapy ) a high level of calcium in the blood ( hypercalcemia ) a low level of potassium in the blood ( hypokalemia ) alcohol abuse viral hepatitis (an infection of the liver ) ... Digit al photographs were taken of the participants and their work. The ...

Hypercalcemia

... and anti tumor medicines ( chemotherapy ) a high level of calcium in the blood ( hypercalcemia ) a low level of potassium in the blood ( hypokalemia ) alcohol abuse viral hepatitis (an infection of the liver ) ... with multiple myeloma and the treatment of patients with documented ...

Leg cramps

... cramps ; giving description, causes, treatment , and prevention of this extremely common condition. Source:MedicineNet ... Watery diarrhea hypokalemia (low blood potassium ), which can cause leg cramps Low acid in the stomach Dehydration Abdominal pain and cramp ing Weight loss ...

More>>

Hypokalemia in Biological Technology

Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia

... be used in patients with hypokalemia, hypomagnesemia, or long QT syndrome. hypokalemia or hypomagnesemia must be corrected prior to Tasigna administration and ... reduction. QT prolongation Tasigna prolongs the QT interval. Correct hypokalemia or hypomagnesemia prior to administration and monitor periodically. Avoid ...

FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia

... more common among Vaprisol-treated patients (3%) than among placebo-treated patients (0%). Other common adverse reactions were headaches (8%, 10%), hypokalemia (22%, 10%), orthostatic hypotension (14%, 6%), and pyrexia (11%, 5%) for Vaprisol 20mg/day and 40mg/day, respectively. For full prescribing ...

EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes

... (12.7%) and malaise (10.9%). The most common adverse reactions by IV route also included petechiae (45.8%), rigors (35.4%), weakness (35.4%) and hypokalemia (31.3%). Because treatment with Vidaza is associated with neutropenia and thrombocytopenia, complete blood counts should be performed as needed ...

FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML

... and patients taking anti- arrhythmic drugs, other medicinal products that lead to QT prolongation, or cumulative high-dose anthracycline therapy. hypokalemia or hypomagnesemia should be corrected prior to SPRYCEL administration. Drug Interactions: Dasatinib is a CYP3A4 substrate. Drugs that may increase ...

Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event

... and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. The most common adverse reactions are vomiting (9%), hypokalemia (7%), hyperglycemia (7%), convulsions (6%), and mental impairments (6%). Do not administer to patients with known hypersensitivity to sodium ...
Other Contents
(Date:9/17/2014)... Present-day Europeans are the descendants of at least ... new study. Previous research suggested that ... farmers. But, a new genetic analysis involving ancient ... of Ancient North Eurasians. Nearly all present-day Europeans ... researchers from Harvard Medical School said. , , ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. 17, 2014 (HealthDay ... why antibiotic-resistant bacteria can thrive in a hospital setting. ... the culprit. They can easily enter bacteria and move from ... makes bacteria drug-resistant, a new study finds. "The plasmids ... class of antibiotic called carbapenems," said the study,s co-author, Dr. ...
(Date:9/17/2014)... might be able to reduce the need for invasive ... autoimmune disease lupus. , In a new study, researchers ... from nephritis kidney inflammation to interstitial fibrosis, ... A kidney biopsy is the only existing way to ... extent. , The model could also be used to ...
(Date:9/17/2014)... 17, 2014 Today, Blue Shield ... in third-quarter grantmaking. This body of grants aims to ... innovations in care delivery, as well as to develop ... Grants will also strengthen the capacity of both domestic ... and create new entry points for domestic violence screening ...
(Date:9/17/2014)... 17, 2014 In a country where ... on a regular basis, how can Americans find healthy ... Hyland’s Stress Challenge , a 5-day interactive journey ... stress-free life. From September 29th – October 3rd, ... content relating to specific topics that promote natural solutions ...
Breaking Medicine News(10 mins):Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 2Health News:Europeans Are Descendants of at Least 3 Ancient Human Groups: Study 3Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3Health News:Math model designed to replace invasive kidney biopsy for lupus patients 2Health News:Blue Shield of California Foundation Awards $5 Million in Third-Quarter Grants 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2
(Date:9/16/2014)... same viruses that make us sick can take up ... a sneeze, cough or other troublesome symptom, according to ... St. Louis. , On average, healthy individuals carry ... researchers report online in BioMed Central Biology . ... the diversity of viruses in healthy people. , ...
(Date:9/16/2014)... the dinosaurs 66 million years ago decimated the evergreens ... than their deciduous peers, according to a study led ... journal PLOS Biology . , Applying biomechanical ... leaves of angiosperms flowering plants excluding conifers ... of a diverse plant community thriving during a 2.2 ...
(Date:9/16/2014)... new school year, a new football season and another ... September, SpaceX,s Dragon spacecraft is scheduled to blast off ... part of the company,s fourth contracted mission to the ... third suite of research investigations sponsored by the Center ... the role of managing the U.S. National Laboratory on ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3
Other TagsOther Tags